Literature DB >> 28052525

Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study.

Hodaka Yamada1, Makoto Kuro-O2, San-E Ishikawa3, Shunsuke Funazaki1, Ikuyo Kusaka1, Masafumi Kakei1, Kazuo Hara1.   

Abstract

AIM: Calciprotein particles (CPPs), colloidal protein-mineral nanoparticles composed of solid-phase calcium phosphate and serum protein fetuin-A found in blood, are emerging as a novel component of chronic kidney disease-mineral and bone disorder (CKD-MBD). The relationship of CPPs with factors known to underlie the CKD-MBD pathophysiology is not well known.The aim of this study is to examine daily variations in CPPs as well as their association with mineral metabolism parameters in normal individuals and early-stage CKD patients.
METHODS: Twenty subjects (10 healthy adults, 10 diabetic patients) were enrolled. Serum CPP Fetuin-A was measured and analyzed in relation to clinical parameters.
RESULTS: Estimated glomerular filtration rates (eGFR) were 103 ± 11 and 75 ± 24 mL/min per 1.73 m2 in healthy adults and diabetic patients, respectively. Serum CPP Fetuin-A (g/L) were elevated at postprandial 2 h in diabetic patients. Furthermore, serum CPP Fetuin-A were inversely correlated with eGFR and serum 1,25-dihydroxyvitamin D3 and magnesium levels and were positively correlated with serum fibroblast growth factor-23.
CONCLUSIONS: These findings indicated that serum CPP Fetuin-A were affected by food intake and may contribute to the pathophysiology of mineral metabolism in subjects with normal and moderately impaired renal function.
© 2017 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  calciprotein particles; chronic kidney disease; diabetes, fibroblast growth factor 23; mineral and bone disorder

Mesh:

Substances:

Year:  2018        PMID: 28052525     DOI: 10.1111/nep.12994

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  8 in total

Review 1.  Phosphate Is a Cardiovascular Toxin.

Authors:  Maren Leifheit-Nestler; Isabel Vogt; Dieter Haffner; Beatrice Richter
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Effect of nutritional calcium and phosphate loading on calciprotein particle kinetics in adults with normal and impaired kidney function.

Authors:  Mark K Tiong; Michael M X Cai; Nigel D Toussaint; Sven-Jean Tan; Andreas Pasch; Edward R Smith
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

Review 3.  Telomere Homeostasis: Interplay with Magnesium.

Authors:  Donogh Maguire; Ognian Neytchev; Dinesh Talwar; Donald McMillan; Paul G Shiels
Journal:  Int J Mol Sci       Date:  2018-01-05       Impact factor: 5.923

4.  Calcium Phosphate Bions Cause Intimal Hyperplasia in Intact Aortas of Normolipidemic Rats through Endothelial Injury.

Authors:  Daria Shishkova; Elena Velikanova; Maxim Sinitsky; Anna Tsepokina; Olga Gruzdeva; Leo Bogdanov; Anton Kutikhin
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

Review 5.  Calciprotein Particles and Serum Calcification Propensity: Hallmarks of Vascular Calcifications in Patients with Chronic Kidney Disease.

Authors:  Ciprian N Silaghi; Tamás Ilyés; Adriana J Van Ballegooijen; Alexandra M Crăciun
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

6.  Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.

Authors:  E R Smith; I Ruderman; S Bruell; K M Nicholls; T D Hewitson; A S Talbot; S G Holt
Journal:  Osteoporos Int       Date:  2022-05-16       Impact factor: 5.071

7.  Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease.

Authors:  Mark K Tiong; Edward R Smith; Nigel D Toussaint; Hasan F Al-Khayyat; Stephen G Holt
Journal:  JBMR Plus       Date:  2021-05-05

8.  A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.

Authors:  Edward R Smith; Tim D Hewitson; Michael M X Cai; Parisa Aghagolzadeh; Matthias Bachtler; Andreas Pasch; Stephen G Holt
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.